166 additive manufacturing companies serving the Bioprinting & Tissue Engineering industry, tracked by AMPulse (top 50 by funding shown below). Browse profiles, funding rounds, and technology details.
Updated
Additive manufacturing in Bioprinting & Tissue Engineering is the use of additive manufacturing to deposit living cells, biomaterials, and bio-inks to construct tissue and organ-like structures for research, drug discovery, and emerging therapeutic applications.
Why AM fits Bioprinting & Tissue Engineering: Bioprinting is the longest-tail AM application: predominantly research-stage today, but with credible therapeutic potential by 2030. Drug discovery (3D tissue models replacing 2D cell cultures), regenerative medicine (cartilage and skin grafts), and personalized cancer treatment screening are the near-term commercial applications.
Common AM processes: extrusion bioprinting, inkjet bioprinting, laser-induced forward transfer (LIFT), VPP with bioink. Typical materials: hydrogels (alginate, collagen, gelatin methacrylate), living cells, growth factors, decellularized extracellular matrix.
A space habitation company developing the world's first commercial artificial gravity space stations to enable long-term human presence in Earth orbit and beyond.
Develops cultivated meat directly from animal cells using biotechnology, aiming to produce sustainable meat products without raising or slaughtering animals.
Provides intellectual property legal services specializing in patent, trademark, copyright, and trade secret law for additive manufacturing and 3D printing companies, protecting innovations and enabling commercialization.
Aspect Biosystems develops bioprinted tissue therapeutics using AI-powered bioprinting technology, computational design tools, advanced biomaterials, and therapeutic cells.
Produces cultivated meat using bioprinting and cellular agriculture technology, creating real animal meat from cells without slaughtering animals.
Organovo develops 3D printed human tissues to revolutionize drug discovery and medical research.
A global leader in high-precision 3D microfabrication, providing laser-based 3D printers that enable sub-micrometer resolution for industrial and scientific applications.
Leader in micro-precision 3D printing using proprietary Projection Micro Stereolithography (PμSL) technology, enabling ultra-high resolution manufacturing down to 2-micron precision for medical devices, electronics, and advanced research applications.
Bioprinting pioneer creating lab-grown human tissues for drug discovery and regenerative medicine
Develops holographic bioprinting technology for creating complex human tissues and lymph node models to enable rapid antibody discovery, reducing lead times from 9 months to 16 days.
A global leader in regenerative medicine that leverages proprietary 3D bioprinting technology to develop bioresorbable medical devices, tissue-derived bio-inks, and cell-based therapeutics.
Inventia Life Science develops world-leading bioprinting technology for advanced medical research, enabling 3D cell culture and tissue engineering applications.
Supplies high-volume, well-characterized adult human mesenchymal stem cells (hMSCs) and engineered media systems for bioprinting and regenerative medicine, reducing cell costs from >$1,000 to <$10 per million cells.
A pioneering regenerative medicine company specializing in biological additive manufacturing, specifically the world's first 3D bioprinted stem cell vascular grafts (REVOVAS) and proprietary 'Biosynsphere' bio-ink technology.
The Regenova 3D bioprinter enables the creation of three-dimensional living tissue constructs using the innovative Kenzan method, which arranges cell spheroids onto needles for scaffold-free tissue construction.
Developing 3D-bioprinted living implants and resorbable surgical meshes to repair or replace damaged human tissues.
A regenerative and aesthetic medicine company developing innovative 3D bioprinting technologies and products based on proprietary plant-derived recombinant human collagen (rhCollagen) for tissue regeneration, organ manufacturing, and medical aesthetics.
4WEB Medical is an orthopedic device company that develops and manufactures 3D-printed titanium implants utilizing a proprietary truss geometry designed to stimulate bone growth and improve surgical outcomes.
Develops and manufactures patient-specific, resorbable bone implants using a proprietary 3D printing technology that are replaced by the patient's own bone over time.
Develops a 4D biofabrication platform for transplantable tissues and organs, combining cell expansion, biomaterials, and printing technology, with initial focus on corneal grafts for ophthalmology.
Develops the Fluidic Factory, the world's first commercial 3D printer for fabricating fluidically sealed microfluidic devices using COC polymer, enabling rapid prototyping of chips for as little as $1 per chip.
Develops a protein-based artificial retina using a layer-by-layer additive manufacturing process in microgravity to restore vision for patients with retinal degenerative diseases like retinitis pigmentosa and age-related macular degeneration.
Integrated research and medical company specializing in iPS and ES cell technologies for drug discovery and regenerative medicine.
Develops and supplies recombinant laminin-based cell culture matrices and bioinks for 3D bioprinting and stem cell research, enabling biologically relevant 3D cell culture environments.
Develops cultivated chicken meat grown directly from animal cells using bioreactor technology, targeting sustainable and animal-friendly protein production.
Develops high-standard collagen-based medical devices and bioprinting materials for tissue regeneration.
Develops and manufactures Tetrapod Quantum Dots for medical diagnostics, display lighting, solar cells, and solid-state lighting through patent-pending volume production; also secured 3D printing technology for embedding quantum dots in products for uncopyable anti-counterfeiting identification.
Biotechnology company pioneering regenerative therapeutics using BioNidum™ bioinspired cell delivery system combining materials science, 3D-printing, and digital manufacturing to create tissue therapeutics that restore organ function lost to disease, trauma, or aging.
Scrona AG offers ultra-high-resolution 3D printing technology for industrial microfabrication using proprietary MEMS-based electrostatic multi-nozzle printheads.
Develops high-purity bio-inks and extracellular matrix materials for 3D bioprinting and tissue engineering applications, enabling reproducible cell culture and research.
Develops 3D bioprinted vascularized organ-on-a-chip models (h-VIOS platform) using hydrogels and human cells for preclinical drug testing, reducing reliance on animal models and accelerating drug discovery timelines.
An ultra-high-precision micro manufacturing and 2-photon polymerization (2PP) micro 3D printing service provider delivering parts with nanometer-scale resolution (0.2 µm) for rapid prototyping to mass production applications.
Provides custom 3D printing manufacturing services and advanced materials development, specializing in ceramics and polymers for industrial applications.
Develops and manufactures medical-grade Collagen Type 0 derived from jellyfish for bioprinting and tissue engineering, addressing risks of traditional mammalian sources.
Developing implantable vascularized human tissue grafts via proprietary high-resolution light-based 3D bioprinting.
BioSapien, founded in 2018, pioneers minimally invasive drug delivery platforms with its signature MediChip™ technology, utilizing 3D printing to deliver targeted chemotherapy directly to tumor sites to minimize side effects.
Distributes high-tech equipment and Concept Laser metal additive manufacturing systems for semiconductor, medical, and research applications in Southeast Asia.
A high-tech biotechnology firm specializing in the industrialization of Bio-3D printing, regenerative synthetic biology, and microfluidic technologies for human-engineered extracellular matrix (hEECM) materials in regenerative medicine and medical aesthetics.
Develops an automated 3D bioprinting platform with integrated machine learning co-pilots to standardize human tissue fabrication for pharmaceutical drug screening.
Distributes 3D bioprinters and scientific lab equipment for research and industrial laboratories, providing consultation and technical support.
A French biotech company developing and producing human tissues using laser-assisted 4D bioprinting for pharmaceutical, cosmetic, and regenerative medicine applications.
Develops parthenogenetic stem cell (hpSC) technology for regenerative medicine, enabling immune-matched cell therapies and research products, with applications in bioprinting and tissue engineering.
A high-resolution 3D screen printing and bioprinting technology company that designs, develops, and manufactures advanced solutions for medical, life science, and cosmetic applications using gentle additive manufacturing processes.
Develops 3D bioprinted hydrogel substrates (Bio-Blocks) for tissue-mimetic cell culture, eliminating subculture to accelerate research and therapeutic development.
Non-profit research institute funding and building the field of cellular agriculture through open research, focusing on cultured meat, milk, and eggs produced via cell culture and bioprinting technologies.
Bioprinting company using Sound Induced Morphogenesis to create skin tissue for wound healing
Develops DLP-based bioprinting technology for high-throughput manufacturing of biomedical devices, cell matrices, and precision human tissues for cell culture, drug screening, therapeutics, and regenerative medicine.
Manufactures high-quality collagen fibers at commercial scale using a patented dry-spinning process for tissue engineering, 3D cell culture, and bioprinting applications.
Submicron-resolution volumetric micro-lithography 3D printing system enabling mass production of complex microstructures at 6mm³/minute speeds—replacing multi-step lithographic processes with single-machine fabrication.
Provides contract research, product development, and stem cell culture training using 3D bioprinting for drug testing and regenerative medicine applications.
Additive manufacturing in Bioprinting & Tissue Engineering is the use of additive manufacturing to deposit living cells, biomaterials, and bio-inks to construct tissue and organ-like structures for research, drug discovery, and emerging therapeutic applications.
AMPulse tracks 166 companies serving the Bioprinting & Tissue Engineering vertical. Leading examples by funding include Vast, Upside Foods, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Aspect Biosystems, and GOOD Meat – Eat Just.
Bioprinting & Tissue Engineering most commonly uses extrusion bioprinting, inkjet bioprinting, laser-induced forward transfer (LIFT), VPP with bioink. Typical materials include hydrogels (alginate, collagen, gelatin methacrylate), living cells, growth factors, decellularized extracellular matrix.
Bioprinting is the longest-tail AM application: predominantly research-stage today, but with credible therapeutic potential by 2030. Drug discovery (3D tissue models replacing 2D cell cultures), regenerative medicine (cartilage and skin grafts), and personalized cancer treatment screening are the near-term commercial applications.